期刊文献+

2型糖尿病合并高甘油三酯血症-腰围表型与非酒精性脂肪性肝病的相关性研究 被引量:5

Association of Nonalcoholic Fatty Liver Disease with Hypertriglyceridaemic Wasit Phenotype Complicated with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)合并高甘油三酯血症-腰围表型(HTWC)与非酒精性脂肪性肝病(NAFLD)之间的关系。方法选取T2DM患者804例,以血三酰甘油≥1.7 mmol/L、腰围男性≥90 cm或女性≥85 cm为切点,分为三酰甘油和腰围正常组、单纯高甘油三酯血症组、单纯腹型肥胖组、HTWC组。记录4组患者的一般临床资料,计算体质指数(BMI)、稳态模型评估的胰岛素抵抗指数(HOMA-IR)和非酒精性脂肪肝纤维化指数(NAFLDFS)。结果 HTWC组患者平均BMI、收缩压、舒张压、HOMA-IR、丙氨酸转氨酶、天冬氨酸转氨酶、γ-谷氨酰转移酶、血尿酸、NAFLDFS及NAFLD发病率均明显高于非HTWC组(均P〈0.01)。Logistic回归分析显示,除BMI、γ-谷氨酰转移酶、血尿酸外,HTWC也是T2DM患者合并NAFLD的危险因素(OR=1.986,95%CI:1.006~3.921)。结论 HTWC是T2DM合并NAFLD的危险因素,重视对HTWC表型者的早期筛查和诊断,使患者尽早获得干预,控制代谢紊乱,有助于减少NAFLD的发生和延缓疾病的进展。 Objective To investigate the association of nonalcoholic fatty liver disease with hypertriglyceridaemicwasit phenotype complicated with type 2 diabetes mellitus. Methods Base on whether plasma triglycerides concentration ≥1.7 mmol/L or not, waist circumference ≥90 cm or not in men or ≥85 cm or not in women, patients with type 2 diabe-tes mellitus(n=804) were divided into four groups: normal waist circumference with normal triglycerides, normal waist cir-cumference with hypertriglyceridemia, abdominal obesity with normal triglycerides and hypertriglyceridemic-waist pheno-type(HTWC). The four groups' clinical data were recorded. Body mass index(BMI), homeostasis model assessment insulinresistance(HOMA-IR) and nonalcoholic fatty liver disease fibrosis score(NAFLDFS) were calculated and the results werecompared among four groups. Results BMI, waist circumference, systolic blood pressure, diastolic blood pressure, HOMA-IR, alanine aminotransferase, aspartate aminotransferase, γ-glutamyltransferase, serum uric acid,NAFLDFS and the inci-dence of NAFLD were all higher in the HTWC group compared to non-HTWC group(P〈0.01). Logistic regression analysisrevealed that besides BMI,γ-glutamyltransferase and serum uric acid,HTWC was also a risk factor for NAFLD in patientswith type 2 diabetes mellitus(OR=1.986,95%CI:1.006-3.921). Conclusion HTWC is a risk factor for NAFLD in patientswith type 2 diabetes mellitus. Screening and diagnosis of HTWC is helpful for reducing the occurrence of NAFLD and canslow its progress through controlling and interfering metabolic disturbance.
作者 丁炜光
出处 《天津医药》 CAS 北大核心 2014年第12期1219-1222,共4页 Tianjin Medical Journal
关键词 脂肪肝 糖尿病 2型 非酒精性脂肪肝 高甘油三酯血症-腰围表型 fatty liver diabetes mellitus type 2 nonalcoholic fatty liver disease hypertriglyceridaemic-waist phenotype
  • 相关文献

参考文献2

二级参考文献152

共引文献5740

同被引文献52

  • 1Adams LA, Harmsen S, St Sauver JL, et al. Non-al coholic fatty liver disease increases risk of death among patients with diabetes .. a community-based cohort study [J]. Am J Gastroenterol,2010,105(7) :1567-1573.
  • 2Angulo P, Hui JM, Marchesini G, et al. The NAFLD fi brosis score: a noninvasive system that identifies liver fibrosis inpatients with NAFLD[J]. Hepatology, 2007, 45(4) :846- 854.
  • 3Xia MF, Yan HM, He WY, et al. Standardized ultra- sound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content:An improvement method[J].Obesity(Silver Spring) ,2012,20(2) :444- 452.
  • 4Chalasani N, Younossi Z, Lavine JE, et al. The Diagno sis and Manageme-nt of Non-Alcoholic Fatty Liver Dis- ease: Practice Guideline by the American Gastroenter ological Association, American Association for the Study of Liver Diseases, and American College of Gas- troenterology[J]. Gastroenterology, 2012,142 (7) :1592- 1609.
  • 5Angulo P, Bugianesi E, Bjornsson ES, et al. Simple non- invasive systems predict long term outcomes of patients with non-alcoholic fatty liver disease[J]. Gastroenterol- ogy,2013,145(4):782 -789.
  • 6Zhou Y J, Li YY, Nie YQ, et al. Natural course of nonal coholic fatty liver disease in southern China:a prospec tire cohort study[J]. J Dig Dis,2012,13(3) :153 -160.
  • 7Hu X, Huang Y, Bao Z, et al. Prevalence and {actors as sociated with non-alcoholic fatty liver disease in shang hai work-units[J]. BMC Gastroenterol, 2012,12: 123.
  • 8Clark JM ,Brancati FL, Diehl AM. Nonalcoholicfatty liv er disease[J]. Gastroenterology, 2002, 122 (6) : 1649 -1657.
  • 9Arem H, Mayne ST, Sampson J, et al. Dietary fat intake and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial [J]. Ann Epidemiol, 2013, 23 (9): 571-575.
  • 10Payton S. Prostate cancer: periprostatic fat is a risk factor for prostate cancer detection [J]. Nat Rev Urol, 2012, 9 (4) : 180.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部